- Report
- April 2025
- 175 Pages
Global
From €3979EUR$4,490USD£3,427GBP
Thymoglobulin is an immunosuppressive drug used to prevent organ rejection in transplant patients. It is a polyclonal antibody derived from human thymus tissue, and works by suppressing the immune system to prevent it from attacking the transplanted organ. Thymoglobulin is also used to treat a variety of autoimmune diseases, such as rheumatoid arthritis, Crohn's disease, and lupus.
Thymoglobulin is available in both intravenous and subcutaneous forms, and is typically administered in a series of doses over a period of several weeks. The drug is generally well-tolerated, with the most common side effects being fever, chills, and nausea.
The thymoglobulin market is a growing segment of the immunosuppressive drug market, with a wide range of products available from various manufacturers. Companies in the market include Genzyme, Novartis, Teva Pharmaceuticals, and Fresenius Kabi. Show Less Read more